N1 Life
Pioneering drug delivery technology company accelerating science to solve unmet medical needs, focusing on drug discovery and development and featuring AbsotrideTM Peptide-based Delivery Platform and ChARLSTM Polymer-based Delivery Platform.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD62—93m (Dealroom.co estimates Apr 2023.)
Milpitas California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $10.0m | Seed | |
| Total Funding | AUD15.5m | ||